Julie Lauffenburger (@jlauffen) 's Twitter Profile
Julie Lauffenburger

@jlauffen

Associate Professor, Health Services Researcher & Pharmacist @BrighamWomens @C4HDS @HarvardMed @HarvardChanSPH | Med adherence/optimization & Pragmatic trials

ID: 4861779154

linkhttps://www.c4hds.org/our-team-1/julie-lauffenburger%2C-pharmd%2C-phd calendar_today29-01-2016 21:59:12

811 Tweet

521 Followers

328 Following

Alexander Chaitoff (@alexchaitoff) 's Twitter Profile Photo

Gabapentin - what is it good for (absolutely nothing?) In this paper, we explore what proportion of gabapentin use has at least some evidence of benefit for patients. #medtwitter #pain 👇1/8 pubmed.ncbi.nlm.nih.gov/37794261/

Julie Lauffenburger (@jlauffen) 's Twitter Profile Photo

This was a fun paper looking more into relationships in medication-taking among families, with huge credit to our former Center for Healthcare Delivery Sciences fellow, Renee Barlev, for getting it started

Center for Healthcare Delivery Sciences (@c4hds) 's Twitter Profile Photo

Nice editorial in Circ: CQO written by Julie Lauffenburger and Cynthia Jackevicius about prescription drug discount programs and out-of-pocket costs in #Cardiovascular disease! ahajournals.org/doi/10.1161/CI…

Julie Lauffenburger (@jlauffen) 's Twitter Profile Photo

Before heading out for some Thanksgiving downtime, I am thankful to share about my promotion last week to Associate Professor - particularly the best to have happened the same day as Rishi J Desai ! Very grateful for mentors, colleagues & trainees especially Center for Healthcare Delivery Sciences

Elad Yom-Tov (@elad1) 's Twitter Profile Photo

Our new study, published yesterday on Nature Digital Medicine tackles medical adherence. A short thread on what we did follows: nature.com/articles/s4174… 1/n

Julie Lauffenburger (@jlauffen) 's Twitter Profile Photo

Thrilled to see our The National Institute on Aging (NIA)-funded trial published! Our findings indicate that personalized text messaging can improve #adherence to medication and using reinforcement learning may be a strategy to implement personalization at scale Thanks to all those involved in the project!

MassAITC (@massaitc) 's Twitter Profile Photo

Reminder in 1 week, join us for “Advances in Cardiovascular Health Monitoring to Support Healthy Aging at Home” 🗓️June 11, 3pm EDT 🔗Register: bit.ly/3WOW5dn FEATURING! Dr. Anna Barnacka, CEO of MindMics Edward J Wang, CEO of Billion Labs | Asst Prof UCSD Engineering

Reminder in 1 week,  join us for  “Advances in Cardiovascular Health Monitoring to Support Healthy Aging at Home” 
🗓️June 11, 3pm EDT 
🔗Register: bit.ly/3WOW5dn 
FEATURING! <a href="/AnnaBarnacka/">Dr. Anna Barnacka</a>, CEO of <a href="/MindMics/">MindMics</a> <a href="/ejaywang/">Edward J Wang</a>, CEO of <a href="/BillionLabsInc/">Billion Labs</a> | Asst Prof <a href="/UCSDJacobs/">UCSD Engineering</a>
Alexander Chaitoff (@alexchaitoff) 's Twitter Profile Photo

New study led by @KatharinaJungo Once an older adult starts a high-risk medication, what factors make them more likely to become chronic users? Turns out it's complicated, but here we break it down by high-risk medication class 👇 #MedTwitter pubmed.ncbi.nlm.nih.gov/39215549/

Center for Healthcare Delivery Sciences (@c4hds) 's Twitter Profile Photo

The Roybal Center for Therapeutic Optimization Using Behavioral Science is thrilled to announce its annual call for pilot project proposals for our next year of funding (beginning June 1, 2025). c4hds.org/roybal-center-… Julie Lauffenburger Niteesh Choudhry The National Institute on Aging (NIA) @NIA_BSR

Circ: CQO (@circoutcomes) 's Twitter Profile Photo

Quantifying Pill Disutility Associated with Starting Versus Continuing Cardioprotective Medication: A Randomized Experiment @alexchaitoff Julie Lauffenburger #AHAJournals ahajrnls.org/3ZLNHwi

Quantifying Pill Disutility Associated with Starting Versus Continuing Cardioprotective Medication: A Randomized Experiment @alexchaitoff <a href="/jlauffen/">Julie Lauffenburger</a> #AHAJournals ahajrnls.org/3ZLNHwi
Julie Lauffenburger (@jlauffen) 's Twitter Profile Photo

New work led by Alexander Chaitoff in Annals of Int Med finding that new use of gabapentin is not associated with greater fall risk than another active comparator - excellent work, Alex! 👏